Pfizer Canada is the Canadian arm of Pfizer’s global biopharmaceutical business and markets medicines and vaccines across a broad range of therapeutic areas. The company’s Canadian operations support commercialization, medical affairs, market access, and external research collaborations tied to innovative prescription products. Its portfolio spans both established therapies and newer biologic, small-molecule, and vaccine programs.